Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Obligate Role of Anti-Apoptotic MCL-1 in the Survival of Hematopoietic Stem Cells
Joseph T. Opferman,1,2*
Hiromi Iwasaki,2
Christy C. Ong,1,2
Heikyung Suh,1,2
Shin-ichi Mizuno,2
Koichi Akashi,2
Stanley J. Korsmeyer1,2
Abstract:
Apoptosis is important in controlling hematopoietic stem cell(HSC) numbers. However, the specific BCL-2 family member(s)that regulate HSC homeostasis are not precisely defined. Wetested myeloid leukemia1 (MCL-1) as an attractive candidatethat is highly expressed in HSCs and regulated by growth factorsignals. Inducible deletion of Mcl-1 in mice resulted in ablationof bone marrow. This resulted in the loss of early bone marrowprogenitor populations, including HSCs. Moreover, growth factorsincluding stem cell factor increased transcription of the Mcl-1gene and required MCL-1 to augment survival of purified bonemarrow progenitors. Deletion of Mcl-1 in other tissues, includingliver, did not impair survival. Thus, MCL-1 is a critical andspecific regulator essential for ensuring the homeostasis ofearly hematopoietic progenitors.
1 Howard Hughes Medical Institute, Department of Cancer Immunology and AIDS, Pathology and Medicine, Harvard Medical School, Boston, MA 02115, USA. 2 Dana Farber Cancer Institute, Department of Cancer Immunology and AIDS, Pathology and Medicine, Harvard Medical School, Boston, MA 02115, USA.
* Present address: Department of Biochemistry, St. Jude Children'sResearch Hospital, 332 North Lauderdale, Memphis, TN 38105,USA.
To whom correspondence should be addressed. E-mail: Koichi_Akashi{at}dfci.harvard.edu (K.A.); Stanley_Korsmeyer{at}dfci.harvard.edu (S.K.)
The editors suggest the following Related Resources on Science sites:
Apc regulates the function of hematopoietic stem cells largely through {beta}-catenin-dependent mechanisms.
W. Li, Y. Hou, M. Ming, L. Yu, A. Seba, and Z. Qian (2013)
Blood
121, 4063-4072
|Abstract »|Full Text »|PDF »
RNAi screening uncovers Dhx9 as a modifier of ABT-737 resistance in an E{mu}-myc/Bcl-2 mouse model.
J. R. Mills, A. Malina, T. Lee, D. Di Paola, O. Larsson, C. Miething, F. Grosse, H. Tang, M. Zannis-Hadjopoulos, S. W. Lowe, et al. (2013)
Blood
121, 3402-3412
|Abstract »|Full Text »|PDF »
Mithramycin A Inhibits Myeloid Cell Leukemia-1 to Induce Apoptosis in Oral Squamous Cell Carcinomas and Tumor Xenograft through Activation of Bax and Oligomerization.
J.-A. Shin, J.-Y. Jung, M. H. Ryu, S. Safe, and S.-D. Cho (2013)
Mol. Pharmacol.
83, 33-41
|Abstract »|Full Text »|PDF »
The BAF53a subunit of SWI/SNF-like BAF complexes is essential for hemopoietic stem cell function.
V. Krasteva, M. Buscarlet, A. Diaz-Tellez, M.-A. Bernard, G. R. Crabtree, and J. A. Lessard (2012)
Blood
120, 4720-4732
|Abstract »|Full Text »|PDF »
Human Cytomegalovirus Stimulates Monocyte-to-Macrophage Differentiation via the Temporal Regulation of Caspase 3.
G. Chan, M. T. Nogalski, and A. D. Yurochko (2012)
J. Virol.
86, 10714-10723
|Abstract »|Full Text »|PDF »
Necdin, a p53 target gene, regulates the quiescence and response to genotoxic stress of hematopoietic stem/progenitor cells.
T. Asai, Y. Liu, S. Di Giandomenico, N. Bae, D. Ndiaye-Lobry, A. Deblasio, S. Menendez, Y. Antipin, B. Reva, R. Wevrick, et al. (2012)
Blood
120, 1601-1612
|Abstract »|Full Text »|PDF »
The thrombopoietin/MPL/Bcl-xL pathway is essential for survival and self-renewal in human preleukemia induced by AML1-ETO.
F.-S. Chou, A. Griesinger, M. Wunderlich, S. Lin, K. A. Link, M. Shrestha, S. Goyama, B. Mizukawa, S. Shen, G. Marcucci, et al. (2012)
Blood
120, 709-719
|Abstract »|Full Text »|PDF »
Mcl-1 and Bcl-xL coordinately regulate megakaryocyte survival.
M. A. Debrincat, E. C. Josefsson, C. James, K. J. Henley, S. Ellis, M. Lebois, K. L. Betterman, R. M. Lane, K. L. Rogers, M. J. White, et al. (2012)
Blood
119, 5850-5858
|Abstract »|Full Text »|PDF »
Selectively targeting Mcl-1 for the treatment of acute myelogenous leukemia and solid tumors.
Anti-apoptotic Mcl-1 is essential for the development and sustained growth of acute myeloid leukemia.
S. P. Glaser, E. F. Lee, E. Trounson, P. Bouillet, A. Wei, W. D. Fairlie, D. J. Izon, J. Zuber, A. R. Rappaport, M. J. Herold, et al. (2012)
Genes & Dev.
26, 120-125
|Abstract »|Full Text »|PDF »
Human cytomegalovirus activation of ERK and myeloid cell leukemia-1 protein correlates with survival of latently infected cells.
TNF-{alpha}/Fas-RIP-1-induced cell death signaling separates murine hematopoietic stem cells/progenitors into 2 distinct populations.
Y. Xiao, H. Li, J. Zhang, A. Volk, S. Zhang, W. Wei, S. Zhang, P. Breslin, and J. Zhang (2011)
Blood
118, 6057-6067
|Abstract »|Full Text »|PDF »
ELK4 neutralization sensitizes glioblastoma to apoptosis through downregulation of the anti-apoptotic protein Mcl-1.
B. W. Day, B. W. Stringer, M. D. Spanevello, S. Charmsaz, P. R. Jamieson, K. S. Ensbey, J. C. Carter, J. M. Cox, V. J. Ellis, C. L. Brown, et al. (2011)
Neuro Oncology
13, 1202-1212
|Abstract »|Full Text »|PDF »
MCL1 increases primitive thymocyte viability in female mice and promotes thymic expansion into adulthood.
J. Gui, A. J. Morales, S. E. Maxey, K. A. Bessette, N. R. Ratcliffe, J. A. Kelly, and R. W. Craig (2011)
Int. Immunol.
23, 647-659
|Abstract »|Full Text »|PDF »
Cooperation between both Wnt/{beta}-catenin and PTEN/PI3K/Akt signaling promotes primitive hematopoietic stem cell self-renewal and expansion.
J. M. Perry, X. C. He, R. Sugimura, J. C. Grindley, J. S. Haug, S. Ding, and L. Li (2011)
Genes & Dev.
25, 1928-1942
|Abstract »|Full Text »|PDF »
A critical role for SHP2 in STAT5 activation and growth factor-mediated proliferation, survival, and differentiation of human CD34+ cells.
L. Li, H. Modi, T. McDonald, J. Rossi, J.-K. Yee, and R. Bhatia (2011)
Blood
118, 1504-1515
|Abstract »|Full Text »|PDF »
Akt-Dependent Glucose Metabolism Promotes Mcl-1 Synthesis to Maintain Cell Survival and Resistance to Bcl-2 Inhibition.
J. L. Coloff, A. N. Macintyre, A. G. Nichols, T. Liu, C. A. Gallo, D. R. Plas, and J. C. Rathmell (2011)
Cancer Res.
71, 5204-5213
|Abstract »|Full Text »|PDF »
Mitochondrion-dependent N-terminal Processing of Outer Membrane Mcl-1 Protein Removes an Essential Mule/Lasu1 Protein-binding Site.
M. R. Warr, J. R. Mills, M. Nguyen, S. Lemaire-Ewing, J. Baardsnes, K. L. W. Sun, A. Malina, J. C. Young, D. V. Jeyaraju, M. O'Connor-McCourt, et al. (2011)
J. Biol. Chem.
286, 25098-25107
|Abstract »|Full Text »|PDF »
Critical role for Gimap5 in the survival of mouse hematopoietic stem and progenitor cells.
Y. Chen, M. Yu, X. Dai, M. Zogg, R. Wen, H. Weiler, and D. Wang (2011)
J. Exp. Med.
208, 923-935
|Abstract »|Full Text »|PDF »
Essential role for Ptpn11 in survival of hematopoietic stem and progenitor cells.
G. Chan, L. S. Cheung, W. Yang, M. Milyavsky, A. D. Sanders, S. Gu, W. X. Hong, A. X. Liu, X. Wang, M. Barbara, et al. (2011)
Blood
117, 4253-4261
|Abstract »|Full Text »|PDF »
Telomerase reverse transcriptase protects ATM-deficient hematopoietic stem cells from ROS-induced apoptosis through a telomere-independent mechanism.
E. Nitta, M. Yamashita, K. Hosokawa, M. Xian, K. Takubo, F. Arai, S. Nakada, and T. Suda (2011)
Blood
117, 4169-4180
|Abstract »|Full Text »|PDF »
Bcr-Abl ubiquitination and Usp9x inhibition block kinase signaling and promote CML cell apoptosis.
H. Sun, V. Kapuria, L. F. Peterson, D. Fang, W. G. Bornmann, G. Bartholomeusz, M. Talpaz, and N. J. Donato (2011)
Blood
117, 3151-3162
|Abstract »|Full Text »|PDF »
Leukemia Stem Cells and Microenvironment: Biology and Therapeutic Targeting.
MicroRNA-125b expands hematopoietic stem cells and enriches for the lymphoid-balanced and lymphoid-biased subsets.
A. G. L. Ooi, D. Sahoo, M. Adorno, Y. Wang, I. L. Weissman, and C. Y. Park (2010)
PNAS
107, 21505-21510
|Abstract »|Full Text »|PDF »
Quercetin Induces Tumor-Selective Apoptosis through Downregulation of Mcl-1 and Activation of Bax.
S. Cheng, N. Gao, Z. Zhang, G. Chen, A. Budhraja, Z. Ke, Y.-o. Son, X. Wang, J. Luo, and X. Shi (2010)
Clin. Cancer Res.
16, 5679-5691
|Abstract »|Full Text »|PDF »
Elevated Mcl-1 perturbs lymphopoiesis, promotes transformation of hematopoietic stem/progenitor cells, and enhances drug resistance.
K. J. Campbell, M. L. Bath, M. L. Turner, C. J. Vandenberg, P. Bouillet, D. Metcalf, C. L. Scott, and S. Cory (2010)
Blood
116, 3197-3207
|Abstract »|Full Text »|PDF »
Expression of the Transcriptional Repressor Gfi-1 Is Regulated by C/EBP{alpha} and Is Involved in Its Proliferation and Colony Formation-Inhibitory Effects in p210BCR/ABL-Expressing Cells.
M. R. Lidonnici, A. Audia, A. R. Soliera, M. Prisco, G. Ferrari-Amorotti, T. Waldron, N. Donato, Y. Zhang, R. V. Martinez, T. L. Holyoake, et al. (2010)
Cancer Res.
70, 7949-7959
|Abstract »|Full Text »|PDF »
Adult hematopoietic stem cells require NKAP for maintenance and survival.
A. G. Pajerowski, M. J. Shapiro, K. Gwin, R. Sundsbak, M. Nelson-Holte, K. Medina, and V. S. Shapiro (2010)
Blood
116, 2684-2693
|Abstract »|Full Text »|PDF »
The human stem cell hierarchy is defined by a functional dependence on Mcl-1 for self-renewal capacity.
C. J. V. Campbell, J. B. Lee, M. Levadoux-Martin, T. Wynder, A. Xenocostas, B. Leber, and M. Bhatia (2010)
Blood
116, 1433-1442
|Abstract »|Full Text »|PDF »
S. Guo, J. Lu, R. Schlanger, H. Zhang, J. Y. Wang, M. C. Fox, L. E. Purton, H. H. Fleming, B. Cobb, M. Merkenschlager, et al. (2010)
PNAS
107, 14229-14234
|Abstract »|Full Text »|PDF »
Hemgn is a direct transcriptional target of HOXB4 and induces expansion of murine myeloid progenitor cells.
J. Jiang, H. Yu, Y. Shou, G. Neale, S. Zhou, T. Lu, and B. P. Sorrentino (2010)
Blood
116, 711-719
|Abstract »|Full Text »|PDF »
Mcl-1 Stability Determines Mitotic Cell Fate of Human Multiple Myeloma Tumor Cells Treated with the Kinesin Spindle Protein Inhibitor ARRY-520.
B. J. Tunquist, R. D. Woessner, and D. H. Walker (2010)
Mol. Cancer Ther.
9, 2046-2056
|Abstract »|Full Text »|PDF »
Ubiquitin-Independent Degradation of Antiapoptotic MCL-1.
D. P. Stewart, B. Koss, M. Bathina, R. M. Perciavalle, K. Bisanz, and J. T. Opferman (2010)
Mol. Cell. Biol.
30, 3099-3110
|Abstract »|Full Text »|PDF »
From Estrogen-Centric to Aging and Oxidative Stress: A Revised Perspective of the Pathogenesis of Osteoporosis.
Critical Requirement of GABP{alpha} for Normal T Cell Development.
S. Yu, D.-M. Zhao, R. Jothi, and H.-H. Xue (2010)
J. Biol. Chem.
285, 10179-10188
|Abstract »|Full Text »|PDF »
PI3K-Dependent Upregulation of Mcl-1 by Human Cytomegalovirus Is Mediated by Epidermal Growth Factor Receptor and Inhibits Apoptosis in Short-Lived Monocytes.
G. Chan, M. T. Nogalski, G. L. Bentz, M. S. Smith, A. Parmater, and A. D. Yurochko (2010)
J. Immunol.
184, 3213-3222
|Abstract »|Full Text »|PDF »
FLT3-ITD up-regulates MCL-1 to promote survival of stem cells in acute myeloid leukemia via FLT3-ITD-specific STAT5 activation.
G. Yoshimoto, T. Miyamoto, S. Jabbarzadeh-Tabrizi, T. Iino, J. L. Rocnik, Y. Kikushige, Y. Mori, T. Shima, H. Iwasaki, K. Takenaka, et al. (2009)
Blood
114, 5034-5043
|Abstract »|Full Text »|PDF »
Activation of Tumor Suppressor Protein p53 Is Required for Theiler's Murine Encephalomyelitis Virus-Induced Apoptosis in M1-D Macrophages.
K.-N. Son, S. Pugazhenthi, and H. L. Lipton (2009)
J. Virol.
83, 10770-10777
|Abstract »|Full Text »|PDF »
Mcl-1 Integrates the Opposing Actions of Signaling Pathways That Mediate Survival and Apoptosis.
C. Morel, S. M. Carlson, F. M. White, and R. J. Davis (2009)
Mol. Cell. Biol.
29, 3845-3852
|Abstract »|Full Text »|PDF »
H. Dai, X. W. Meng, S.-H. Lee, P. A. Schneider, and S. H. Kaufmann (2009)
J. Biol. Chem.
284, 18311-18322
|Abstract »|Full Text »|PDF »
Selective roles for antiapoptotic MCL-1 during granulocyte development and macrophage effector function.
D. A. Steimer, K. Boyd, O. Takeuchi, J. K. Fisher, G. P. Zambetti, and J. T. Opferman (2009)
Blood
113, 2805-2815
|Abstract »|Full Text »|PDF »
Promoter Knock-In Mutations Reveal a Role of Mcl-1 in Thymocyte-Positive Selection and Tissue or Cell Lineage-Specific Regulation of Mcl-1 Expression.
C.-Y. Yang, N.-H. Lin, J.-M. Lee, C.-Y. Huang, H.-J. Min, J. J.-Y. Yen, N.-S. Liao, and H.-F. Yang-Yen (2009)
J. Immunol.
182, 2959-2968
|Abstract »|Full Text »|PDF »
Mll5 contributes to hematopoietic stem cell fitness and homeostasis.
Y. Zhang, J. Wong, M. Klinger, M. T. Tran, K. M. Shannon, and N. Killeen (2009)
Blood
113, 1455-1463
|Abstract »|Full Text »|PDF »
Glucose Metabolism Attenuates p53 and Puma-dependent Cell Death upon Growth Factor Deprivation.
Y. Zhao, J. L. Coloff, E. C. Ferguson, S. R. Jacobs, K. Cui, and J. C. Rathmell (2008)
J. Biol. Chem.
283, 36344-36353
|Abstract »|Full Text »|PDF »
Stat5 regulates cellular iron uptake of erythroid cells via IRP-2 and TfR-1.
M. A. Kerenyi, F. Grebien, H. Gehart, M. Schifrer, M. Artaker, B. Kovacic, H. Beug, R. Moriggl, and E. W. Mullner (2008)
Blood
112, 3878-3888
|Abstract »|Full Text »|PDF »
A critical role for Apc in hematopoietic stem and progenitor cell survival.
Z. Qian, L. Chen, A. A. Fernald, B. O. Williams, and M. M. Le Beau (2008)
J. Exp. Med.
205, 2163-2175
|Abstract »|Full Text »|PDF »
hKSR-2, a vitamin D-regulated gene, inhibits apoptosis in arabinocytosine-treated HL60 leukemia cells.
X. Wang, R. Patel, and G. P. Studzinski (2008)
Mol. Cancer Ther.
7, 2798-2806
|Abstract »|Full Text »|PDF »
Steel factor coordinately regulates the molecular signature and biologic function of hematopoietic stem cells.
D. G. Kent, B. J. Dykstra, J. Cheyne, E. Ma, and C. J. Eaves (2008)
Blood
112, 560-567
|Abstract »|Full Text »|PDF »
TAK1 is required for the survival of hematopoietic cells and hepatocytes in mice.
M. Tang, X. Wei, Y. Guo, P. Breslin, S. Zhang, S. Zhang, W. Wei, Z. Xia, M. Diaz, S. Akira, et al. (2008)
J. Exp. Med.
205, 1611-1619
|Abstract »|Full Text »|PDF »
The Anti-Apoptotic Bcl-2 Family Member Mcl-1 Promotes T Lymphocyte Survival at Multiple Stages.
Mcl-1 Is a Key Regulator of Apoptosis during CNS Development and after DNA Damage.
N. Arbour, J. L. Vanderluit, J. N. Le Grand, A. Jahani-Asl, V. A. Ruzhynsky, E. C. C. Cheung, M. A. Kelly, A. E. MacKenzie, D. S. Park, J. T. Opferman, et al. (2008)
J. Neurosci.
28, 6068-6078
|Abstract »|Full Text »|PDF »
Human Flt3 Is Expressed at the Hematopoietic Stem Cell and the Granulocyte/Macrophage Progenitor Stages to Maintain Cell Survival.
Y. Kikushige, G. Yoshimoto, T. Miyamoto, T. Iino, Y. Mori, H. Iwasaki, H. Niiro, K. Takenaka, K. Nagafuji, M. Harada, et al. (2008)
J. Immunol.
180, 7358-7367
|Abstract »|Full Text »|PDF »
Bmi1 regulates memory CD4 T cell survival via repression of the Noxa gene.
M. Yamashita, M. Kuwahara, A. Suzuki, K. Hirahara, R. Shinnaksu, H. Hosokawa, A. Hasegawa, S. Motohashi, A. Iwama, and T. Nakayama (2008)
J. Exp. Med.
205, 1109-1120
|Abstract »|Full Text »|PDF »
Bcl-2-family proteins and hematologic malignancies: history and future prospects.
Novel Pro-survival Functions of the Kruppel-like Transcription Factor Egr2 in Promotion of Macrophage Colony-stimulating Factor-mediated Osteoclast Survival Downstream of the MEK/ERK Pathway.
E. W. Bradley, M. M. Ruan, and M. J. Oursler (2008)
J. Biol. Chem.
283, 8055-8064
|Abstract »|Full Text »|PDF »
A novel BH3 ligand that selectively targets Mcl-1 reveals that apoptosis can proceed without Mcl-1 degradation.
E. F. Lee, P. E. Czabotar, M. F. van Delft, E. M. Michalak, M. J. Boyle, S. N. Willis, H. Puthalakath, P. Bouillet, P. M. Colman, D. C.S. Huang, et al. (2008)
J. Cell Biol.
180, 341-355
|Abstract »|Full Text »|PDF »
Down-Regulation of Mcl-1 by Small Interfering RNA Sensitizes Resistant Melanoma Cells to Fas-Mediated Apoptosis.
N. Chetoui, K. Sylla, J.-V. Gagnon-Houde, C. Alcaide-Loridan, D. Charron, R. Al-Daccak, and F. Aoudjit (2008)
Mol. Cancer Res.
6, 42-52
|Abstract »|Full Text »|PDF »
The N Terminus of the Anti-apoptotic BCL-2 Homologue MCL-1 Regulates Its Localization and Function.
Cited2 is required for normal hematopoiesis in the murine fetal liver.
Y. Chen, P. Haviernik, K. D. Bunting, and Y.-C. Yang (2007)
Blood
110, 2889-2898
|Abstract »|Full Text »|PDF »
The Multikinase Inhibitor Sorafenib Induces Apoptosis in Highly Imatinib Mesylate-Resistant Bcr/Abl+ Human Leukemia Cells in Association with Signal Transducer and Activator of Transcription 5 Inhibition and Myeloid Cell Leukemia-1 Down-Regulation.
M. Rahmani, T. K. Nguyen, P. Dent, and S. Grant (2007)
Mol. Pharmacol.
72, 788-795
|Abstract »|Full Text »|PDF »
N-terminal Truncation of Antiapoptotic MCL1, but Not G2/M-induced Phosphorylation, Is Associated with Stabilization and Abundant Expression in Tumor Cells.
A. De Biasio, J. A. Vrana, P. Zhou, L. Qian, C. K. Bieszczad, K. E. Braley, A. M. Domina, S. J. Weintraub, J. M. Neveu, W. S. Lane, et al. (2007)
J. Biol. Chem.
282, 23919-23936
|Abstract »|Full Text »|PDF »
Requirements for survivin in terminal differentiation of erythroid cells and maintenance of hematopoietic stem and progenitor cells.
C. G. Leung, Y. Xu, B. Mularski, H. Liu, S. Gurbuxani, and J. D. Crispino (2007)
J. Exp. Med.
204, 1603-1611
|Abstract »|Full Text »|PDF »
Serine 64 Phosphorylation Enhances the Antiapoptotic Function of Mcl-1.
S. Kobayashi, S.-H. Lee, X. W. Meng, J. L. Mott, S. F. Bronk, N. W. Werneburg, R. W. Craig, S. H. Kaufmann, and G. J. Gores (2007)
J. Biol. Chem.
282, 18407-18417
|Abstract »|Full Text »|PDF »
Glycogen Synthase Kinase 3{alpha} and 3{beta} Mediate a Glucose-Sensitive Antiapoptotic Signaling Pathway To Stabilize Mcl-1.
Y. Zhao, B. J. Altman, J. L. Coloff, C. E. Herman, S. R. Jacobs, H. L. Wieman, J. A. Wofford, L. N. Dimascio, O. Ilkayeva, A. Kelekar, et al. (2007)
Mol. Cell. Biol.
27, 4328-4339
|Abstract »|Full Text »|PDF »
Functional Linkage between NOXA and Bim in Mitochondrial Apoptotic Events.
J. Han, L. A. Goldstein, W. Hou, and H. Rabinowich (2007)
J. Biol. Chem.
282, 16223-16231
|Abstract »|Full Text »|PDF »
De novo DNA methyltransferase is essential for self-renewal, but not for differentiation, in hematopoietic stem cells.
Y. Tadokoro, H. Ema, M. Okano, E. Li, and H. Nakauchi (2007)
J. Exp. Med.
204, 715-722
|Abstract »|Full Text »|PDF »
Structural insights into the degradation of Mcl-1 induced by BH3 domains.
P. E. Czabotar, E. F. Lee, M. F. van Delft, C. L. Day, B. J. Smith, D. C. S. Huang, W. D. Fairlie, M. G. Hinds, and P. M. Colman (2007)
PNAS
104, 6217-6222
|Abstract »|Full Text »|PDF »
W. Yuan, J. E. Payton, M. S. Holt, D. C. Link, M. A. Watson, J. F. DiPersio, and T. J. Ley (2007)
Blood
109, 961-970
|Abstract »|Full Text »|PDF »
Anti-Apoptotic MCL-1 Plays a Critical Role in Maintenance of Normal and Malignant Human Hematopoietic Stem Cells through FLT3 Signaling..
G. Yoshimoto, T. Miyamoto, T. Iino, Y. Kikushige, H. Niiro, H. Iwasaki, M. Harada, and K. Akashi (2006)
Blood (ASH Annual Meeting Abstracts)
108, 11
|Abstract »|PDF »
The Protein Kinase C{delta} Catalytic Fragment Targets Mcl-1 for Degradation to Trigger Apoptosis.
L. A. Sitailo, S. S. Tibudan, and M. F. Denning (2006)
J. Biol. Chem.
281, 29703-29710
|Abstract »|Full Text »|PDF »
An Internal EELD Domain Facilitates Mitochondrial Targeting of Mcl-1 via a Tom70-dependent Pathway.
C.-H. Chou, R.-S. Lee, and H.-F. Yang-Yen (2006)
Mol. Biol. Cell
17, 3952-3963
|Abstract »|Full Text »|PDF »
Mcl-1L cleavage is involved in TRAIL-R1- and TRAIL-R2-mediated apoptosis induced by HGS-ETR1 and HGS-ETR2 human mAbs in myeloma cells.
E. Menoret, P. Gomez-Bougie, A. Geffroy-Luseau, S. Daniels, P. Moreau, S. Le Gouill, J.-L. Harousseau, R. Bataille, M. Amiot, and C. Pellat-Deceunynck (2006)
Blood
108, 1346-1352
|Abstract »|Full Text »|PDF »
The Three-Substituted Indolinone Cyclin-Dependent Kinase 2 Inhibitor 3-[1-(3H-Imidazol-4-yl)-meth-(Z)-ylidene]-5-methoxy-1,3-dihydro-indol-2-one (SU9516) Kills Human Leukemia Cells via Down-Regulation of Mcl-1 through a Transcriptional Mechanism.
N. Gao, L. Kramer, M. Rahmani, P. Dent, and S. Grant (2006)
Mol. Pharmacol.
70, 645-655
|Abstract »|Full Text »|PDF »
Cyclooxygenase-2 Inhibition Induces Apoptosis Signaling via Death Receptors and Mitochondria in Hepatocellular Carcinoma..
M. A. Kern, A. M. Haugg, A. F. Koch, T. Schilling, K. Breuhahn, H. Walczak, B. Fleischer, C. Trautwein, C. Michalski, H. Schulze-Bergkamen, et al. (2006)
Cancer Res.
66, 7059-7066
|Abstract »|Full Text »|PDF »
Lack of {alpha}4 integrin expression in stem cells restricts competitive function and self-renewal activity.
G. V. Priestley, L. M. Scott, T. Ulyanova, and T. Papayannopoulou (2006)
Blood
107, 2959-2967
|Abstract »|Full Text »|PDF »
Herceptin Sensitizes ErbB2-Overexpressing Cells to Apoptosis by Reducing Antiapoptotic Mcl-1 Expression.
E. S. Henson, X. Hu, and S. B. Gibson (2006)
Clin. Cancer Res.
12, 845-853
|Abstract »|Full Text »|PDF »
Mcl-1 Is Essential for the Survival of Synovial Fibroblasts in Rheumatoid Arthritis.
H. Liu, P. Eksarko, V. Temkin, G. K. Haines III, H. Perlman, A. E. Koch, B. Thimmapaya, and R. M. Pope (2005)
J. Immunol.
175, 8337-8345
|Abstract »|Full Text »|PDF »
Phase I and Pharmacokinetic Study of Flavopiridol followed by 1-{beta}-D-Arabinofuranosylcytosine and Mitoxantrone in Relapsed and Refractory Adult Acute Leukemias.
J. E. Karp, A. Passaniti, I. Gojo, S. Kaufmann, K. Bible, T. S. Garimella, J. Greer, J. Briel, B. D. Smith, S. D. Gore, et al. (2005)
Clin. Cancer Res.
11, 8403-8412
|Abstract »|Full Text »|PDF »
Apoptosis Induced by the Kinase Inhibitor BAY 43-9006 in Human Leukemia Cells Involves Down-regulation of Mcl-1 through Inhibition of Translation.
M. Rahmani, E. M. Davis, C. Bauer, P. Dent, and S. Grant (2005)
J. Biol. Chem.
280, 35217-35227
|Abstract »|Full Text »|PDF »
c-Myc rapidly induces acute myeloid leukemia in mice without evidence of lymphoma-associated antiapoptotic mutations.
H. Luo, Q. Li, J. O'Neal, F. Kreisel, M. M. Le Beau, and M. H. Tomasson (2005)
Blood
106, 2452-2461
|Abstract »|Full Text »|PDF »
BH3-only proteins in control: specificity regulates MCL-1 and BAK-mediated apoptosis.
C. Gelinas and E. White (2005)
Genes & Dev.
19, 1263-1268
|Full Text »|PDF »
Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins.
S. N. Willis, L. Chen, G. Dewson, A. Wei, E. Naik, J. I. Fletcher, J. M. Adams, and D. C.S. Huang (2005)
Genes & Dev.
19, 1294-1305
|Abstract »|Full Text »|PDF »